sn-2 Palmitate (OPO) — The Infant Formula Atlas

By María López Botín · Mother of 2, researching infant formula and infant nutrition since 2018

sn-2 palmitate, often written OPO on ingredient lists, is the structured-lipid solution to the palm oil absorption problem explained in our palm oil explainer. It's the same palmitic acid that appears in standard palm oil, but attached to the glycerol backbone in a different position, and that geometric difference changes how the infant absorbs fat and calcium. The science is settled: sn-2 palmitate formulas produce softer stools, better calcium absorption, and improved fat uptake compared to standard-palm-oil formulas.

Triglyceride positional chemistry showing sn-1, sn-2, sn-3 positions on the glycerol backbone, with palm oil's palmitic acid predominantly at sn-1/sn-3 (forms calcium soaps) versus breast milk's palmitic acid at sn-2 (absorbed freely), and the enzymatic restructuring that creates sn-2 palmitate-enriched formula fats — In palm oil, ~90% of palmitic acid sits at sn-1/sn-3 positions on the triglyceride. These positions release palmitic acid during digestion; it binds calcium to form insoluble soaps → harder stools and reduced mineral absorption. Breast milk has ~70% of palmitic at sn-2 position (middle), absorbed freely. sn-2 palmitate-enriched formulas enzymatically restructure palm oil to recreate breast milk's pattern.

The fat-chemistry primer

Triglycerides, the molecules that make up dietary fat, consist of a glycerol backbone with three fatty acids attached at positions labeled sn-1, sn-2, and sn-3. Human breast milk palmitic acid is located predominantly (~70%) at the sn-2 position. Standard palm oil used in infant formula places palmitic acid predominantly (~80%) at sn-1 and sn-3.

This positional difference matters because of how pancreatic lipase works in the infant gut:

Pancreatic lipase cleaves fatty acids specifically from the sn-1 and sn-3 positions.
The sn-2 fatty acid stays attached to the glycerol as a 2-monoglyceride, which is absorbed intact.
If palmitic acid is released as a free fatty acid from sn-1 or sn-3 (as happens with standard palm oil), it can bind calcium in the alkaline intestinal lumen to form insoluble calcium-palmitate soaps.
These calcium soaps are excreted rather than absorbed, taking both calcium and fat with them.

The result of standard palm oil: modestly reduced calcium absorption, modestly reduced fat absorption, and firmer stools (because the calcium soaps contribute to stool hardness).

What sn-2 palmitate does about it

sn-2 palmitate is produced by enzymatically rearranging standard palm oil to move palmitic acid from sn-1/sn-3 to sn-2, mimicking the breast milk triglyceride structure. Once the palmitic acid is at sn-2, it stays attached to the 2-monoglyceride through digestion, is absorbed as a unit, and doesn't participate in calcium-soap formation.

Clinical outcomes of sn-2 palmitate formulas vs standard palm oil formulas:

Softer, more frequent stools, closer to the breastfed baseline.
Improved calcium absorption, measurably higher in several randomized trials.
Improved bone mineralization, documented in longer-term follow-up studies.
Better overall fat absorption, modest but consistent effect.

Which formulas use sn-2 palmitate

sn-2 palmitate is the "premium" differentiator in structured-lipid infant formulas:

US brands, some Enfamil Premium and Bobbie Organic variants use it.
Specialty EU brands, limited adoption; most EU organic brands use standard (though organic-certified) palm oil in their vegetable oil blends.
Kendamil approach: Kendamil bypasses the sn-2 question entirely by using whole milk fat instead of a vegetable-oil blend. The fat profile in whole milk already has palmitic acid predominantly at sn-2, matching breast milk naturally without any enzymatic rearrangement.

So parents wanting to solve the palm-oil absorption question have two functionally equivalent options: an sn-2 palmitate (OPO) formula, or a whole-milk-fat formula like Kendamil. Both deliver the same calcium-absorption and stool-consistency benefits through different routes.

Our Infant Formula Atlas lets you filter by fat-source approach, the palm-oil filter shows whole-milk-fat alternatives, and individual SKU records document which specific fat-structure approach each formula uses.

How sn-2 palmitate appears on labels

Ingredient labels for sn-2 palmitate formulas may list any of:

sn-2 palmitate
OPO (oleic-palmitic-oleic triglyceride)
Structured vegetable oil or structured triglycerides
β-palmitate (less common)

A parent who wants to verify sn-2 presence in a specific formula should look for any of these phrasings on the ingredient list, or for the specific marketing callout (many brands highlight OPO/sn-2 as a differentiator on the front of the package).

Cost and trade-offs

sn-2 palmitate is more expensive to produce than standard palm oil, the enzymatic rearrangement adds a processing step. This is the main reason most mass-market formulas stick with standard palm oil, and why sn-2 versions are typically positioned as "premium" or "gentle" variants with correspondingly higher price points.

The clinical difference is real but modest. A healthy infant tolerating a standard palm oil formula well does not necessarily benefit from switching to sn-2; a parent whose baby has hard stools, slow weight gain, or concerns about calcium absorption may find the switch worthwhile.

What this means in practice

The decision tree for a parent considering the palm-oil question is simple enough once the chemistry is clear:

If the baby is thriving on their current formula, don't switch on the basis of the palm-oil debate alone. The difference is real but modest.
If the baby has persistently hard stools, constipation, or slow weight gain, and you're using a standard-palm-oil formula, an sn-2 palmitate formula or a whole-milk-fat formula like Kendamil is a reasonable next move. Discuss with your pediatrician first.
If you prefer to avoid palm oil entirely on sustainability or principle-based grounds, Kendamil is the most widely available whole-milk-fat option. Some US brands also offer palm-free formulations.

The Infant Formula Atlas records the specific fat-blend composition for every documented SKU, so you can compare the palm oil status across brands without reading a dozen manufacturer websites.

Finally: sn-2 palmitate vs standard palm oil is one axis among many when choosing a formula. The lactose-as-primary-carb question, the protein source, the DHA content, the prebiotic presence all matter and may outweigh the palm-oil structural decision for any given baby. Our brand hubs cover the full trade-off space per brand rather than treating any single ingredient as dispositive.

Frequently asked questions

What is sn-2 palmitate?

Sn-2 palmitate is a structured triglyceride where palmitic acid (the saturated fat from palm oil) is positioned at the sn-2 (middle) position of the glycerol backbone — matching how palmitic acid is configured in human breast milk. Standard palm oil places palmitic acid in the sn-1 and sn-3 (outer) positions, which causes calcium soap formation during infant digestion. The sn-2 restructuring is achieved enzymatically and produces a palm-derived fat that digests like breast milk fat.

Why does sn-2 position matter for digestion?

During infant digestion, pancreatic lipase preferentially cleaves fatty acids from the sn-1 and sn-3 positions of triglycerides, leaving the sn-2 fatty acid attached to the glycerol monoester. When palmitic acid is at sn-1/sn-3 (standard palm oil), it gets released as free palmitic acid that binds dietary calcium, forming insoluble calcium soaps that pass through stool — producing harder stools and reduced calcium absorption. When palmitic acid is at sn-2 (breast milk and sn-2 palmitate), it stays attached to glycerol and is absorbed efficiently without calcium binding.

Which infant formulas use sn-2 palmitate?

Kabrita Goat (US-marketed) uses sn-2 palmitate (Betapol™) prominently as a key formulation feature. Some specialty premium formulas also include it. The technology is more common in Asian and Middle Eastern infant formulas. In the US-imported European market, sn-2 palmitate is less common because brands like Kendamil bypass the issue entirely by using whole milk fat (which naturally has palmitic acid at sn-2).

Is sn-2 palmitate the same as 'OPO' or 'Betapol'?

Yes, with nuance. OPO stands for 1,3-Oleic-2-Palmitic-Oleic triglyceride — the specific structured triglyceride where palmitic acid is at sn-2 and oleic acid at sn-1/sn-3. Betapol™ is Bunge Loders Croklaan's commercial brand name for OPO. Both terms refer to enzymatically restructured palm oil with palmitic acid at sn-2. They can be considered functionally equivalent for parents reading labels.

Is sn-2 palmitate better than whole milk fat?

Both achieve the same outcome — palmitic acid at sn-2 position matching breast milk. Sn-2 palmitate is a structured palm oil engineered to match breast milk's pattern. Whole milk fat (Kendamil, ByHeart) preserves the natural sn-2 palmitate that exists in cow milk, plus the broader range of milk fat globule components (MFGM phospholipids, sphingomyelin, cholesterol). Whole milk fat provides a broader nutritional profile; sn-2 palmitate provides targeted palmitic acid delivery without the broader milk fat components.

Why isn't sn-2 palmitate more common in US formulas?

Sn-2 palmitate adds production cost — the enzymatic restructuring is more expensive than using standard palm oil. Most US mainstream formulas (Similac, Enfamil) use standard palm oil for cost reasons. Premium US formulas have generally bypassed the issue by using whole milk fat (ByHeart) or omitting palm oil entirely (Bobbie's vegetable oil blend without palm). Sn-2 palmitate has historically been more common in Israeli (Materna) and Asian formulas, with Kabrita bringing the technology to broader US awareness through its goat milk line.

Primary sources

Kennedy K et al. Double-blind, randomized trial of a synthetic triacylglycerol (sn-2 palmitate) in term-infant formula. American Journal of Clinical Nutrition. pubmed.ncbi.nlm.nih.gov/12586971
Koletzko B et al. Palm oil and palmitic acid in infant formula: systematic review. European Journal of Nutrition, 2019. pubmed.ncbi.nlm.nih.gov/30545042
EFSA Panel on Dietetic Products. Scientific opinion on the essential composition of infant formula. efsa.europa.eu
Havlicekova Z et al. sn-2 palmitate and infant outcomes: review of clinical trials. Nutrients, 2016. pubmed.ncbi.nlm.nih.gov/24402661

Brands and comparisons featuring sn-2 palmitate or palm-oil-free fat blends, HiPP brand hub (sn-2 palmitate-enriched variants), Kendamil brand hub (whole-milk fat, naturally sn-2 positioned), Bobbie brand hub (palm-oil-free), HiPP vs Bobbie (palm oil present vs absent, in context)
EU Regulation 2016/127 overview
How formula brands compare, fat composition

This site provides research and comparisons, not medical advice. Consult your pediatrician before changing your baby's formula.

Formulas containing sn-2 palmitate (opo)

Primary sources